Royal Bank Of Canada Vanda Pharmaceuticals Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 46,501 shares of VNDA stock, worth $206,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,501

Previous 58,062 19.91%

Holding current value

$206,464

Previous $328,000 33.54%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $53,296 - $73,296	-11,561 Reduced 19.91%	46,501 $218,000
Q2 2024 Aug 14, 2024	SELL	$3.91 - $6.5 $43,471 - $72,267	-11,118 Reduced 16.07%	58,062 $328,000
Q1 2024 Nov 05, 2024	BUY	$3.47 - $4.61 $38,579 - $51,253	11,118 Added 19.15%	69,180 $284,000
Q1 2024 May 15, 2024	BUY	$3.47 - $4.61 $105,470 - $140,120	30,395 Added 78.37%	69,180 $284,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $118,381 - $160,409	-35,024 Reduced 47.45%	38,785 $163,000
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $6,848 - $10,512	-1,600 Reduced 2.12%	73,809 $318,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $39,889 - $46,988	6,761 Added 9.85%	75,409 $496,000
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $290,070 - $375,026	46,937 Added 216.19%	68,648 $466,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $3,270 - $5,216	476 Added 2.24%	21,711 $160,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $2,643 - $3,292	280 Added 1.34%	21,235 $210,000
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $456 - $580	49 Added 0.23%	20,955 $229,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $7,761 - $11,849	-716 Reduced 3.31%	20,906 $236,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $910 - $1,226	-58 Reduced 0.27%	21,622 $340,000
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $11,251 - $15,590	733 Added 3.5%	21,680 $372,000
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $329,077 - $450,569	20,947 New	20,947 $451,000

Others Institutions Holding VNDA

# of Institutions

160

Shares Held

45M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $251M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Vanda Pharmaceuticals Inc. Transaction History